Your browser doesn't support javascript.
loading
Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity-modulated radiotherapy for resectable pancreatic cancer: A prospective, open-label, phase II study.
Masui, Toshihiko; Nagai, Kazuyuki; Anazawa, Takayuki; Kasai, Yosuke; Yogo, Akitada; Yoshimura, Michio; Mizowaki, Takashi; Uza, Norimitsu; Fukuda, Akihisa; Matsumoto, Shigemi; Kanai, Masashi; Isoda, Hiroyoshi; Kawaguchi, Yoshiya; Uemoto, Shinji; Hatano, Etsuro.
Afiliação
  • Masui T; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Nagai K; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Anazawa T; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kasai Y; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yogo A; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Yoshimura M; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Mizowaki T; Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Uza N; Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.
  • Fukuda A; Department of Gastroenterology and Hepatology, Kyoto University, Kyoto, Japan.
  • Matsumoto S; Department of Real World Data Research and Development, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kanai M; Department of Clinical Oncology, Kyoto University, Kyoto, Japan.
  • Isoda H; Department of Diagnostic Imaging and Nuclear Medicine, Kyoto University, Kyoto, Japan.
  • Kawaguchi Y; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Uemoto S; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Hatano E; Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Cancer Med ; 12(18): 18611-18621, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37649318
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article